RBC Europe’s ARK Genomic Revolution ETF ARKG Stock Holding History

RBC Europe’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,508	Closed	-$187K	–	662
2021 Q3	$187K	Hold	2,508	–	–	0.01%	310
2021 Q2	$232K	Hold	2,508	–	–	0.01%	291
2021 Q1	$223K	Buy	2,508 +2,215	+756%	+$220K	0.01%	282
2020 Q4	$27.3K	Buy	293 +153	+109%	+$12.2K	﹤0.01%	641
2020 Q3	$8.92K	Hold	140	–	–	﹤0.01%	822
2020 Q2	$7.3K	Hold	140	–	–	﹤0.01%	823
2020 Q1	$4.38K	Hold	140	–	–	﹤0.01%	843
2019 Q4	$4.69K	Hold	140	–	–	﹤0.01%	906
2019 Q3	$4.13K	Hold	140	–	–	﹤0.01%	910
2019 Q2	$4.83K	Hold	140	–	–	﹤0.01%	917
2019 Q1	$4.6K	Sell	140 -180	-56%	-$5.32K	﹤0.01%	935
2018 Q4	$7.67K	Hold	320	–	–	﹤0.01%	849
2018 Q3	$10.7K	Buy	320 +140	+78%	+$4.43K	﹤0.01%	836
2018 Q2	$5.23K	Hold	180	–	–	﹤0.01%	963
2018 Q1	$4.63K	Hold	180	–	–	﹤0.01%	960
2017 Q4	$4.41K	Hold	180	–	–	﹤0.01%	976
2017 Q3	$4.72K	Buy	+180	New	+$4.23K	﹤0.01%	958

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RBC Europe's ARKG Position: Q4 2021 in Review

RBC Europe sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 2,508 shares — an estimated $187K sold.

RBC Europe first reported a position in ARKG in Q3 2017 and held it in 17 quarters. The position peaked at $232K in Q2 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

RBC Europe reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 2,508 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $187K.
RBC Europe first reported a position in ARK Genomic Revolution ETF in Q3 2017 and held it in 17 quarters.
RBC Europe's ARK Genomic Revolution ETF position peaked at $232K in Q2 2021.
460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.